Clinical trial

Use of AI in Cardiometabolic Risk Prediction in Asian Indians

NCT05939869

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

OTHER · Unmapped registry intervention Medical and Clinical History Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Use of AI in Cardiometabolic Risk Prediction in Asian Indians

Design: OBSERVATIONAL · Status: UNKNOWN · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2023-07-01

PhaseN/A

Conditions

Type2diabetesunresolved

Interventions

Medical and Clinical HistoryOTHER

Sponsors & collaborators

Diabetes Foundation, Indialead sponsor

National Diabetes Obesity and Cholesterol Foundationcollaborator

Johns Hopkins Universitycollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05939869 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.